Prof. Dr. med. Pietro Vernazza
Pandemische Influenza A(H12N1)v-Impfung 2009/10
Hoffmann M, Siegrist C, Vernazza P. Pandemische Influenza A(H12N1)v-Impfung 2009/10. Swiss Medical Forum 2009; 44:788-790.
29.10.2009Pandemische Influenza A(H12N1)v-Impfung 2009/10
29.10.2009Swiss Medical Forum 2009; 44:788-790
Hoffmann Matthias, Siegrist Claire-Anne, Vernazza Pietro
Pandemische Influenza A(H1N1)v 2009 – wir sind gewappnet
Hoffmann M, Schlegel M, Vernazza P. Pandemische Influenza A(H1N1)v 2009 – wir sind gewappnet. Swiss Med Forum 2009; 9:582-585.
07.09.2009Pandemische Influenza A(H1N1)v 2009 – wir sind gewappnet
07.09.2009Swiss Med Forum 2009; 9:582-585
Hoffmann Matthias, Schlegel Matthias, Vernazza Pietro
How reliable is an undetectable viral load?
Combescure C, Hirschel B, Vernazza P, Bernasconi E, Battegay M, Rauch A, Furrer H, Cavassini M, Ledergerber B, Vallier N, Swiss HIV Cohort Study. How reliable is an undetectable viral load?. HIV medicine 2009; 10:470-6.
01.09.2009How reliable is an undetectable viral load?
01.09.2009HIV medicine 2009; 10:470-6
Combescure Christophe, Hirschel B, Vernazza Pietro, Bernasconi E, Battegay M, Rauch A, Furrer H, Cavassini M, Ledergerber B, Vallier N, Swiss HIV Cohort Study
Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy
Young J, Bucher H, Battegay M, Vernazza P, Tarr P, Hirschel B, Furrer H, Rickenbach M, Bernasconi E, Glass T, Swiss HIV Cohort Study. Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy. Journal of clinical epidemiology 2009; 62:632-41.
01.06.2009Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy
01.06.2009Journal of clinical epidemiology 2009; 62:632-41
Young Jim, Bucher Heiner C, Battegay Manuel, Vernazza Pietro, Tarr Philip E, Hirschel Bernard, Furrer Hansjakob, Rickenbach Martin, Bernasconi Enos, Glass Tracy R, Swiss HIV Cohort Study
Accurate QuantiFERON Gold InTube® (QFT) Performance in Haemodialysis (HD) Patients
Hoffmann M, Fierz W, Tsinalis D, Vernazza P, Binet F (2009). Accurate QuantiFERON Gold InTube® (QFT) Performance in Haemodialysis (HD) Patients.
30.05.2009Accurate QuantiFERON Gold InTube® (QFT) Performance in Haemodialysis (HD) Patients
30.05.2009-
Hoffmann Matthias, Fierz Walter, Tsinalis Dimitrios, Vernazza Pietro, Binet Françoise-Isabelle
Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study
Khanna N, Hirsch H, Battegay M, Bernasconi E, Vernazza P, Fux C, Cavassini M, Garzoni C, Mueller N, Elzi L, Swiss HIV Cohort Study. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:1459-66.
15.05.2009Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study
15.05.2009Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:1459-66
Khanna Nina, Hirsch Hans H, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Fux Christoph A, Cavassini Matthias, Garzoni Christian, Mueller Nicolas J, Elzi Luigia, Swiss HIV Cohort Study
JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy
Khanna N, Hirsch H, Battegay M, Viscidi R, Bernasconi E, Vernazza P, Fux C, Du Pasquier R, Garzoni C, Mueller N, Wolbers M, Swiss HIV Cohort Study. JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy. Journal of virology 2009; 83:4404-11.
01.05.2009JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy
01.05.2009Journal of virology 2009; 83:4404-11
Khanna Nina, Hirsch Hans H, Battegay Manuel, Viscidi Raphael, Bernasconi Enos, Vernazza Pietro, Fux Christoph A, Du Pasquier Renaud A, Garzoni Christian, Mueller Nicolas J, Wolbers Marcel, Swiss HIV Cohort Study
Unusually high HIV infectiousness in an HIV-, HCV- and HSV-2-coinfected heterosexual man
Witteck A, Yerly S, Vernazza P. Unusually high HIV infectiousness in an HIV-, HCV- and HSV-2-coinfected heterosexual man. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2009; 139:207-9.
04.04.2009Unusually high HIV infectiousness in an HIV-, HCV- and HSV-2-coinfected heterosexual man
04.04.2009Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2009; 139:207-9
Witteck Andrea, Yerly Sabine, Vernazza Pietro
Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland
von Wyl V, Günthard H, Ledergerber B, Bonhoeffer S, Francioli P, Vernazza P, Hirschel B, Furrer H, Cavassini M, Bernasconi E, Battegay M, Klimkait T, Bürgisser P, Yerly S, Swiss HIV Cohort Study. Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:979-87.
01.04.2009Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland
01.04.2009Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:979-87
von Wyl Viktor, Günthard Huldrych F, Ledergerber Bruno, Bonhoeffer Sebastian, Francioli Patrick, Vernazza Pietro, Hirschel Bernard, Furrer Hansjakob, Cavassini Matthias, Bernasconi Enos, Battegay Manuel, Klimkait Thomas, Bürgisser Philippe, Yerly Sabine, Swiss HIV Cohort Study
Lack of clinical and scientific evidence to justify the systematic use of ICSI in HIV-serodiscordant couples wishing to conceive where the male partner is infected
Bujan L, Gilling-Smith C, Hollander L, Semprini E, Vernazza P. Lack of clinical and scientific evidence to justify the systematic use of ICSI in HIV-serodiscordant couples wishing to conceive where the male partner is infected. Fertility and sterility 2009; 91:e1-2; author reply e2.
01.03.2009Lack of clinical and scientific evidence to justify the systematic use of ICSI in HIV-serodiscordant couples wishing to conceive where the male partner is infected
01.03.2009Fertility and sterility 2009; 91:e1-2; author reply e2
Bujan Louis, Gilling-Smith Carole, Hollander Lital, Semprini Enrico A, Vernazza Pietro
Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study
Bellini C, Cavassini M, Telenti A, Bernasconi E, Vernazza P, Weber R, Kaiser L, Fehr J, Evison J, Chave J, Keiser O, Swiss HIV Cohort Study. Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study. HIV medicine 2009; 10:12-8.
01.01.2009Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study
01.01.2009HIV medicine 2009; 10:12-8
Bellini C, Cavassini M, Telenti A, Bernasconi E, Vernazza Pietro, Weber R, Kaiser L, Fehr J, Evison Jm, Chave J-P, Keiser O, Swiss HIV Cohort Study
[Diagnostic and treatment of HIV-affected couples who wish to have children]
Tandler-Schneider A, Friese K, Schafberger A, Klumb S, Schmied B, Vernazza P, Weigel M, Kremer H, Meurer A, Gingelmaier A, Sonnenberg-Schwan U, Brockmeyer N. [Diagnostic and treatment of HIV-affected couples who wish to have children]. Deutsche medizinische Wochenschrift (1946) 2009; 134 Suppl 1:S34-9.
01.01.2009[Diagnostic and treatment of HIV-affected couples who wish to have children]
01.01.2009Deutsche medizinische Wochenschrift (1946) 2009; 134 Suppl 1:S34-9
Tandler-Schneider A, Friese K, Schafberger A, Klumb S, Schmied B, Vernazza Pietro, Weigel M, Kremer H, Meurer A, Gingelmaier A, Sonnenberg-Schwan U, Brockmeyer N H
Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study
Conen A, Battegay M, Bucher H, Bernasconi E, Cavassini M, Hirschel B, Vernazza P, Weber R, Furrer H, Glass T, Fehr J, Swiss HIV Cohort Study. Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study. Antiviral therapy 2009; 14:349-57.
01.01.2009Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study
01.01.2009Antiviral therapy 2009; 14:349-57
Conen Anna, Battegay Manuel, Bucher Heiner C, Bernasconi Enos, Cavassini Matthias, Hirschel Bernard, Vernazza Pietro, Weber Rainer, Furrer Hansjakob, Glass Tracy R, Fehr Jan, Swiss HIV Cohort Study
Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals
Elzi L, Battegay M, Bernasconi E, Vernazza P, Hirschel B, Cavassini M, Fux C, Weber R, Kaufmann G, Swiss HIV Cohort Study. Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals. HIV clinical trials 2009; 10:207-14.
01.01.2009Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals
01.01.2009HIV clinical trials 2009; 10:207-14
Elzi Luigia, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Hirschel Bernard, Cavassini Matthias, Fux Christoph A, Weber Rainer, Kaufmann Gilbert, Swiss HIV Cohort Study
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV
Young J, Battegay M, Bernasconi E, Vernazza P, Cavassini M, Hirschel B, Fux C, Rickenbach M, Guenthard H, Bucher H, Swiss HIV Cohort Study. Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV. Antiviral therapy 2009; 14:771-9.
01.01.2009Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV
01.01.2009Antiviral therapy 2009; 14:771-9
Young Jim, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Cavassini Matthias, Hirschel Bernard, Fux Christoph A, Rickenbach Martin, Guenthard Huldrych F, Bucher Heiner C, Swiss HIV Cohort Study
Diagnostics and treatment of HIV-affected couples who wish to have children
Tandler-Schneider A, Friese K, Kupka M, Schafberger A, Klumb S, Schmied B, Vernazza P, Weigel M, Kremer H, Meurer A, Gingelmaier A, Sonnenberg-Schwan U, Brockmeyer N. Diagnostics and treatment of HIV-affected couples who wish to have children. European journal of medical research 2008; 13:546-51.
03.12.2008Diagnostics and treatment of HIV-affected couples who wish to have children
03.12.2008European journal of medical research 2008; 13:546-51
Tandler-Schneider A, Friese K, Kupka M, Schafberger A, Klumb S, Schmied B, Vernazza Pietro, Weigel M, Kremer H, Meurer A, Gingelmaier A, Sonnenberg-Schwan U, Brockmeyer N H
Accuracy of an Interferon-gamma Release Assay for the Diagnosis of Latent Tuberculosis Infection in Haemodialysis Patients
Hoffmann M, Tsinalis D, Vernazza P, Fierz W, Binet F (2008). Accuracy of an Interferon-gamma Release Assay for the Diagnosis of Latent Tuberculosis Infection in Haemodialysis Patients.
03.12.2008Accuracy of an Interferon-gamma Release Assay for the Diagnosis of Latent Tuberculosis Infection in Haemodialysis Patients
03.12.200840th meeting of the Swiss Society of Nephrology (SSN-SGN)
Hoffmann Matthias, Tsinalis Dimitrios, Vernazza Pietro, Fierz Walter, Binet Françoise-Isabelle
HIV transmission under highly active antiretroviral therapy
Vernazza P, Hirschel B, Bernasconi E, Flepp M. HIV transmission under highly active antiretroviral therapy. Lancet 2008; 372:1806-7; author reply 1807.
22.11.2008HIV transmission under highly active antiretroviral therapy
22.11.2008Lancet 2008; 372:1806-7; author reply 1807
Vernazza Pietro, Hirschel Bernard, Bernasconi Enos, Flepp Markus
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy
Khanna N, Kaufmann G, Battegay M, Hirschel B, Weber R, Bernasconi E, Vernazza P, Cavassini M, Furrer H, Opravil M, Swiss HIV Cohort Study. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008; 47:1093-101.
15.10.2008CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy
15.10.2008Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008; 47:1093-101
Khanna Nina, Kaufmann Gilbert R, Battegay Manuel, Hirschel Bernard, Weber Rainer, Bernasconi Enos, Vernazza Pietro, Cavassini Matthias, Furrer Hansjakob, Opravil Milos, Swiss HIV Cohort Study
A prospective evaluation of the feasibility and utility of additional tools to obtain information from recently diagnosed HIV infected patients
Daneel S, Schüpbach J, Gebhardt M, Werner M, Staub R, Vernazza P. A prospective evaluation of the feasibility and utility of additional tools to obtain information from recently diagnosed HIV infected patients. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2008; 138:453-8.
09.08.2008A prospective evaluation of the feasibility and utility of additional tools to obtain information from recently diagnosed HIV infected patients
09.08.2008Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2008; 138:453-8
Daneel Synove, Schüpbach J, Gebhardt M, Werner M, Staub R, Vernazza Pietro